Trials Sponsors Conditions Drugs Pricing

Conditions

HIV Infections

Keywords

Drug Therapy, CombinationReverse Transcriptase InhibitorsAnti-HIV AgentsViral Load

Interventions

EmivirineDrug

HydroxyureaDrug

NevirapineDrug

StavudineDrug

DidanosineDrug

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years+

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

You may be eligible for this study if you:
Are at least 18 years old.

Sponsors & Collaborators

Triangle Pharmaceuticals
Industrycollaborator
Bristol-Myers Squibb
Industrylead
Boehringer Ingelheim

Study Sites (5)

Pacific Oaks Med Group

Beverly Hills, California, 90211, United States

Univ of Colorado / Health Science Ctr

Denver, Colorado, 80262, United States

AIDS Research Consortium of Atlanta

Atlanta, Georgia, 30308, United States

Brown Univ School of Medicine

Providence, Rhode Island, 02908, United States

Hampton Roads Med Specialists

Hampton, Virginia, 23666, United States

MeSH Terms

Conditions

HIV Infections

Interventions

emivirineHydroxyureaNevirapineStavudineDidanosine

Condition Hierarchy (Ancestors)

Blood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus Infections

Study Design

Study Type: interventional
Phase: phase 2
Purpose: TREATMENT
Sponsor Type: INDUSTRY

Study Record Dates

First Submitted

November 2, 1999

First Posted

August 31, 2001

Last Updated

August 14, 2008

Record last verified: 2000-03

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00002418
Data provider: ClinicalTrials.gov
Source updated: 2008-08-14
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:39:18 UTC

The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (5)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record

Locations

You may not qualify if:

Intervention Hierarchy (Ancestors)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Conditions

Keywords

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (5)

MeSH Terms

Conditions

Interventions

Condition Hierarchy (Ancestors)

Study Design

Study Record Dates

Source record

Locations

You may not qualify if:

Intervention Hierarchy (Ancestors)